Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/1/1999
 
First Published:
7/1/1998
1.
Phase III Randomized Study of Matrix Metalloprotease Inhibitor AG3340 in Combination with Paclitaxel and Carboplatin in Patients with Recurrent or Metastatic Non-Small Cell Lung Cancer (Summary Last Modified 12/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
AG-3340-006
Last Modified:
5/21/2007
 
First Published:
7/1/1998
2.
Phase III Randomized Study of Matrix Metalloprotease Inhibitor AG3340 in Combination with Mitoxantrone and Prednisone in Patients with Hormone Refractory Prostate Cancer (Summary Last Modified 09/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
AG-3340-009
NCT00003343
Last Modified:
6/1/2007
 
First Published:
1/1/2000
3.
Phase III Randomized Study of Prinomastat (AG3340) or Placebo in Combination With Gemcitabine and Cisplatin in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer (Summary Last Modified 09/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
AG-3340-017
NCT00004199
Last Modified:
6/1/2007
 
First Published:
1/1/2000
4.
Phase II Randomized Study of Prinomastat (AG3340) or Placebo and Temozolomide Following Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme (Summary Last Modified 02/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
16 and over
Pharmaceutical / Industry
AG-3340-019
MCC-12151, MDA-DM-99254, MSKCC-99116, NCT00004200
Last Modified:
12/1/2000
 
First Published:
12/1/2000
5.
Phase II Randomized Study of Paclitaxel With or Without Prinomastat (AG3340) in Patients With Metastatic Melanoma (Summary Last Modified 12/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
AG-3340-022
UCHSC-COMIRB-99958, UCHSC-WIRB-20000020
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute